We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.83 | -0.55% | 149.09 | 149.89 | 147.82 | 149.89 | 3,291,551 | 18:42:07 |
From May 2022 to May 2024
By Kathryn Hardison
Johnson & Johnson's Kenvue Inc., which will be its stand-alone company for consumer health brands, has filed for an initial public offering.
The offering is part of Kenvue's previously disclosed separation from Johnson & Johnson, which will continue to be the name of the company housing its prescription-drug and medical-devices units. Kenvue will oversee brands such as Band-Aid and Tylenol.
Kenvue has filed for an initial public offering with the Securities and Exchange Commission, though it didn't disclose the financial details of the planned offering in a Wednesday filing.
The company said that all of the net proceeds from the sale of shares in the offering will be paid to Johnson & Johnson.
Kenvue will apply to list its shares under the ticker KVUE.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
January 04, 2023 17:19 ET (22:19 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
